查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600207

蛋白质体学市场：按技术、设备类型、服务、应用和最终用户划分 - 全球预测 2025-2030

Proteomics Market by Technology (Chromatography, Edman Sequencing, Electrophoresis), Instrument Type (Analytical Instruments, Reagents & Consumables, Software), Services, Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023 年蛋白质体学市场价值为 317.8 亿美元，预计到 2024 年将达到 360.5 亿美元，预计复合年增长率为 14.67%，到 2030 年达到 829 亿美元。

蛋白质体学是研究蛋白质及其结构和功能的一个广泛领域，对于理解生物过程和机制至关重要。核心蛋白质体学研究范围从蛋白质鑑定到交互作用分析，为个人化医疗和药物发现的进步做出了贡献。对蛋白质体学的需求在于它有可能阐明复杂的细胞功能并提供对疾病机制和治疗性介入有效性的更深入的了解。应用范围包括临床诊断、生物标记发现和系统生物学，最终用途包括製药、生物技术和学术研究。根据市场洞察，关键的成长要素包括质谱技术的进步、药物发现研究活动的增加以及对个人化医疗的需求不断增长。潜在的商机比比皆是，包括开发下一代蛋白质组学技术、扩展到开拓的新兴市场以及建立策略伙伴关係以增强研发能力。为了抓住这些机会，公司应该专注于开发具有成本效益的高通量技术，同时倡导增加蛋白质体学领域的资金和合作。然而，该市场也面临高成本、技术复杂等限制，这对更广泛的采用构成了主要障碍。标准分散、缺乏熟练劳动力以及资料管理挑战使成长前景更加复杂。儘管存在这些挑战，潜在的创新领域包括蛋白质组学与基因组学和其他体学领域的整​​合、人工智慧主导的资料分析工具的开发以及提高可重复性的方法标准化等。蛋白质体学市场本质上是动态和竞争的，其特点是技术快速创新和不断发展，因此参与者必须保持敏捷的策略来应对挑战和满足新兴需求。为了保持竞争力，公司应继续投资于研发，促进跨学科合作，并优先考虑以客户为中心的方法，以满足不断变化的市场需求。

主要市场统计
基准年[2023] 317.8亿美元
预测年份 [2024] 360.5亿美元
预测年份 [2030] 829亿美元
复合年增长率（%） 14.67%

市场动态：揭示快速发展的蛋白质体学市场的关键市场洞察

蛋白质体学市场正在因供需的动态交互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 癌症治疗的使用不断增加以及个人化医疗的需求
    • 更多采用生物资讯学软体和服务进行蛋白质体学研究
    • 人类蛋白质体组织和蛋白质体标准的政府倡议
  • 市场限制因素
    • 与蛋白质体资料储存库管理相关的高成本
  • 市场机会
    • 大量投资蛋白质体技术研发
    • 蛋白质体学生物标誌物发现的新投资
  • 市场挑战
    • 蛋白质体学中胜肽鑑定的局限性

波特五力：驾驭蛋白质体学市场的策略工具

波特的五力框架是了解蛋白质体市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解蛋白质体学市场的外部影响

外部宏观环境因素在塑造蛋白质体学市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解蛋白质体学市场的竞争格局

蛋白质体学市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来发现自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵蛋白质体学市场供应商绩效评估

FPNV 定位矩阵是评估蛋白质体学市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製蛋白质体学市场的成功之路

蛋白质体学市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 癌症治疗的使用不断增加以及个人化医疗的需求
      • 在蛋白质体学研究中更多地采用生物资讯学软体和服务
      • 政府关于人类蛋白质体组织和蛋白质体标准的倡议
    • 抑制因素
      • 与蛋白质体资料储存库管理相关的高成本
    • 机会
      • 大量投资蛋白质体技术研发
      • 蛋白质体生物标记发现的新投资
    • 任务
      • 蛋白质体学中胜肽鑑定的局限性
  • 市场区隔分析
    • 技术：由于精度和可靠性，对层析法的需求不断增加
    • 应用：在临床诊断中利用蛋白质体学进行早期疾病检测、预后与个人化治疗策略
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章蛋白质体学市场：依技术分类

  • 层析法
    • 亲和层析法
    • 气相层析法
    • 离子层析法
    • 液相层析法
    • 表面层析法
  • 埃德曼序列
  • 电泳
    • 毛细管电泳
    • 凝胶电泳
  • 质谱分析
    • 傅立叶转换质谱分析
    • 串联式质谱法
  • 蛋白质部分
  • 蛋白质微阵列
    • 生物晶片
    • 功能蛋白微阵列
  • 表面等离子体共振
  • X射线结晶结构分析

第 7 章按仪器类型分類的蛋白质体学市场

  • 分析设备
    • 层析法设备
    • 光谱仪
  • 试剂/耗材
    • 缓衝
    • 染料
  • 软体
    • 生物资讯资料库
    • 生物资讯学工具
    • 资料采集软体
    • 资料分析软体

第 8 章蛋白质体学市场：依服务分类

  • 生物资讯服务
  • 核心蛋白质体学服务

第 9 章蛋白质体学市场：依应用分类

  • 生物标记鑑定
    • 癌症生物标记
    • 心血管生物标记
  • 临床诊断
    • 疾病诊断
    • 治疗药物监测
  • 药物发现
    • 先导化合物的鑑定
    • 目标识别

第 10 章蛋白质体学市场：依最终使用者分类

  • 学术研究所
    • 核心研究设施
    • 大学实验室
  • 医院和诊断中心
    • 临床检验科
    • 病理实验室
  • 製药公司
    • 药品生产单位
    • 研发机构

第十一章美洲蛋白质体学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十二章亚太蛋白质体市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十三章欧洲、中东和非洲的蛋白质体学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第14章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • SPOC Proteomics 推出用于 Beta 测试的可自订 SPOC 生物感测器，并宣布突破性 SPR 技术将改变蛋白质体学。
    • 布鲁克推出 timsTOF Ultra 2，这是一款最先进的质谱仪，可透过先进的软体整合增强单细胞蛋白质体学。
    • Biognosys 和 Alamar Biosciences 合作整合 NULISA 检测并为 DIA-MS 平台提供支持，以进行高级蛋白质组学研究
  • 战略分析和建议

公司名单

  • Agilent Technologies, Inc.
  • Applied Biomics, Inc.
  • Bio-Rad Laboratories, Inc.
  • Biognosys AG
  • Bruker Corporation
  • Cellenion SASU by Bico Group AB
  • Charles River Laboratories, Inc.
  • Creative Biolabs, Inc.
  • Creative Proteomics
  • Danaher Corporation
  • GE Healthcare
  • Illumina, Inc.
  • IsoPlexis Corporation
  • Luminex Corporation
  • Merck KGaA
  • MRM Proteomics, Inc.
  • Nautilus Biotechnology Inc.
  • NEO Proteomics, Inc.
  • Olink Holding AB
  • Perkinelmer, Inc.
  • Poochon Scientific, LLC
  • Precision Proteomics Inc.
  • Promega Corporation
  • PROMISE Proteomics
  • Proteome Sciences PLC
  • Proteomics International
  • Shantani Proteome Analytics Pvt. Ltd.
  • Thermo Fisher Scientific, Inc.
  • VProteomics
  • Waters Corporation
Product Code: MRR-434CCDA04CE5

The Proteomics Market was valued at USD 31.78 billion in 2023, expected to reach USD 36.05 billion in 2024, and is projected to grow at a CAGR of 14.67%, to USD 82.90 billion by 2030.

Proteomics, an extensive field of study of proteins, their structures, and functions, is crucial in understanding biological processes and mechanisms. At its core, the scope of proteomics extends from identifying proteins to analyzing their interactions, helping drive advances in personalized medicine and drug discovery. The necessity of proteomics lies in its potential to unravel complex cellular functions, offering deeper insights into disease mechanisms and the effectiveness of therapeutic interventions. Its applications span clinical diagnostics, biomarker discovery, and systems biology, with end-use sectors including pharmaceuticals, biotechnology, and academic research. Market insights indicate that key growth factors include advancements in mass spectrometry technology, increasing research activities in drug discovery, and rising demand for personalized medicine. Potential opportunities abound, such as developing next-generation proteomics technologies, expanding into untapped emerging markets, and forging strategic partnerships to enhance R&D capabilities. To seize these opportunities, businesses should focus on developing cost-effective and high-throughput technologies while simultaneously advocating for increased funding and collaboration in the proteomics field. However, the market also faces limitations, such as the high cost of instruments and technical complexity, which pose significant barriers to broader adoption. Fragmentation in standardization, lack of skilled personnel, and data management challenges further complicate growth prospects. Despite these challenges, promising areas for innovation include integrating proteomics with genomics and other omics domains, developing AI-driven data analysis tools, and enhancing method standardization to improve reproducibility. The proteomics market is inherently dynamic and competitive, characterized by rapid technological innovations and constant evolution, making it essential for players to maintain agile strategies to address challenges and meet emerging demands. To remain competitive, companies should commit to continuous investment in R&D, foster interdisciplinary collaborations, and prioritize customer-centric approaches that align with evolving market needs.

KEY MARKET STATISTICS
Base Year [2023] USD 31.78 billion
Estimated Year [2024] USD 36.05 billion
Forecast Year [2030] USD 82.90 billion
CAGR (%) 14.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Proteomics Market

The Proteomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing use in cancer treatment and need for personalized medicine
    • Rise in adoption of bioinformatics software & services for proteomics studies
    • Government initiatives for human proteome organization and proteomics standards
  • Market Restraints
    • High cost associated with proteomics data repository management
  • Market Opportunities
    • Significant investment in research & developments of proteomics technique
    • Emerging investments in proteomics biomarker discovery
  • Market Challenges
    • Peptide identification limitations in proteomics

Porter's Five Forces: A Strategic Tool for Navigating the Proteomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Proteomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Proteomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Proteomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Proteomics Market

A detailed market share analysis in the Proteomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Proteomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Proteomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Proteomics Market

A strategic analysis of the Proteomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Proteomics Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Applied Biomics, Inc., Bio-Rad Laboratories, Inc., Biognosys AG, Bruker Corporation, Cellenion SASU by Bico Group AB, Charles River Laboratories, Inc., Creative Biolabs, Inc., Creative Proteomics, Danaher Corporation, GE Healthcare, Illumina, Inc., IsoPlexis Corporation, Luminex Corporation, Merck KGaA, MRM Proteomics, Inc., Nautilus Biotechnology Inc., NEO Proteomics, Inc., Olink Holding AB, Perkinelmer, Inc., Poochon Scientific, LLC, Precision Proteomics Inc., Promega Corporation, PROMISE Proteomics, Proteome Sciences PLC, Proteomics International, Shantani Proteome Analytics Pvt. Ltd., Thermo Fisher Scientific, Inc., VProteomics, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Proteomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Technology, market is studied across Chromatography, Edman Sequencing, Electrophoresis, Mass Spectrometry, Protein Fractionation, Protein Microarrays, Surface Plasmon Resonance, and X Ray Crystallography. The Chromatography is further studied across Affinity Chromatography, Gas Chromatography, Ion Chromatography, Liquid Chromatography, and Superficial Chromatography. The Electrophoresis is further studied across Capillary Electrophoresis and Gel Electrophoresis. The Mass Spectrometry is further studied across Fourier Transform Mass Spectrometry and Tandem Mass Spectrometry. The Protein Microarrays is further studied across Biochip and Functional Protein Microarray.
  • Based on Instrument Type, market is studied across Analytical Instruments, Reagents & Consumables, and Software. The Analytical Instruments is further studied across Chromatography Instruments and Spectrometers. The Reagents & Consumables is further studied across Buffers and Stains & Dyes. The Software is further studied across Bioinformatics Databases, Bioinformatics Tools, Data Acquisition Software, and Data Analysis Software.
  • Based on Services, market is studied across Bioinformatics Services and Core Proteomics Services.
  • Based on Application, market is studied across Biomarker Identification, Clinical Diagnostics, and Drug Discovery. The Biomarker Identification is further studied across Cancer Biomarkers and Cardiovascular Biomarkers. The Clinical Diagnostics is further studied across Disease Diagnosis and Therapeutic Drug Monitoring. The Drug Discovery is further studied across Lead Compound Identification and Target Identification.
  • Based on End User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Centers, and Pharmaceutical Companies. The Academic & Research Institutes is further studied across Core Research Facilities and University Labs. The Hospital & Diagnostic Centers is further studied across Clinical Testing Departments and Pathology Labs. The Pharmaceutical Companies is further studied across Drug Manufacturing Unit and R&D Laboratories.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing use in cancer treatment and need for personalized medicine
      • 5.1.1.2. Rise in adoption of bioinformatics software & services for proteomics studies
      • 5.1.1.3. Government initiatives for human proteome organization and proteomics standards
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with proteomics data repository management
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant investment in research & developments of proteomics technique
      • 5.1.3.2. Emerging investments in proteomics biomarker discovery
    • 5.1.4. Challenges
      • 5.1.4.1. Peptide identification limitations in proteomics
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Technology: Rising demand for chromatography due to the precision and reliability
    • 5.2.2. Application: Utilization of proteomics in clinical diagnostics for early disease detection, prognosis, and personalized treatment strategies
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Proteomics Market, by Technology

  • 6.1. Introduction
  • 6.2. Chromatography
    • 6.2.1. Affinity Chromatography
    • 6.2.2. Gas Chromatography
    • 6.2.3. Ion Chromatography
    • 6.2.4. Liquid Chromatography
    • 6.2.5. Superficial Chromatography
  • 6.3. Edman Sequencing
  • 6.4. Electrophoresis
    • 6.4.1. Capillary Electrophoresis
    • 6.4.2. Gel Electrophoresis
  • 6.5. Mass Spectrometry
    • 6.5.1. Fourier Transform Mass Spectrometry
    • 6.5.2. Tandem Mass Spectrometry
  • 6.6. Protein Fractionation
  • 6.7. Protein Microarrays
    • 6.7.1. Biochip
    • 6.7.2. Functional Protein Microarray
  • 6.8. Surface Plasmon Resonance
  • 6.9. X Ray Crystallography

7. Proteomics Market, by Instrument Type

  • 7.1. Introduction
  • 7.2. Analytical Instruments
    • 7.2.1. Chromatography Instruments
    • 7.2.2. Spectrometers
  • 7.3. Reagents & Consumables
    • 7.3.1. Buffers
    • 7.3.2. Stains & Dyes
  • 7.4. Software
    • 7.4.1. Bioinformatics Databases
    • 7.4.2. Bioinformatics Tools
    • 7.4.3. Data Acquisition Software
    • 7.4.4. Data Analysis Software

8. Proteomics Market, by Services

  • 8.1. Introduction
  • 8.2. Bioinformatics Services
  • 8.3. Core Proteomics Services

9. Proteomics Market, by Application

  • 9.1. Introduction
  • 9.2. Biomarker Identification
    • 9.2.1. Cancer Biomarkers
    • 9.2.2. Cardiovascular Biomarkers
  • 9.3. Clinical Diagnostics
    • 9.3.1. Disease Diagnosis
    • 9.3.2. Therapeutic Drug Monitoring
  • 9.4. Drug Discovery
    • 9.4.1. Lead Compound Identification
    • 9.4.2. Target Identification

10. Proteomics Market, by End User

  • 10.1. Introduction
  • 10.2. Academic & Research Institutes
    • 10.2.1. Core Research Facilities
    • 10.2.2. University Labs
  • 10.3. Hospital & Diagnostic Centers
    • 10.3.1. Clinical Testing Departments
    • 10.3.2. Pathology Labs
  • 10.4. Pharmaceutical Companies
    • 10.4.1. Drug Manufacturing Unit
    • 10.4.2. R&D Laboratories

11. Americas Proteomics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Proteomics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Proteomics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. SPOC Proteomics launched customizable SPOC biosensors for beta testing, announcing breakthrough SPR technology set to transform proteomics
    • 14.3.2. Bruker launched timsTOF Ultra 2, a state-of-the-art mass spectrometry device enhancing single-cell proteomics with advanced software integration
    • 14.3.3. Biognosys and Alamar Biosciences partner to integrate NULISA assays and enhance DIA-MS platform for advanced proteomics research
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Agilent Technologies, Inc.
  • 2. Applied Biomics, Inc.
  • 3. Bio-Rad Laboratories, Inc.
  • 4. Biognosys AG
  • 5. Bruker Corporation
  • 6. Cellenion SASU by Bico Group AB
  • 7. Charles River Laboratories, Inc.
  • 8. Creative Biolabs, Inc.
  • 9. Creative Proteomics
  • 10. Danaher Corporation
  • 11. GE Healthcare
  • 12. Illumina, Inc.
  • 13. IsoPlexis Corporation
  • 14. Luminex Corporation
  • 15. Merck KGaA
  • 16. MRM Proteomics, Inc.
  • 17. Nautilus Biotechnology Inc.
  • 18. NEO Proteomics, Inc.
  • 19. Olink Holding AB
  • 20. Perkinelmer, Inc.
  • 21. Poochon Scientific, LLC
  • 22. Precision Proteomics Inc.
  • 23. Promega Corporation
  • 24. PROMISE Proteomics
  • 25. Proteome Sciences PLC
  • 26. Proteomics International
  • 27. Shantani Proteome Analytics Pvt. Ltd.
  • 28. Thermo Fisher Scientific, Inc.
  • 29. VProteomics
  • 30. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. PROTEOMICS MARKET RESEARCH PROCESS
  • FIGURE 2. PROTEOMICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL PROTEOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL PROTEOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PROTEOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. PROTEOMICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. PROTEOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. PROTEOMICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL PROTEOMICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PROTEOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PROTEOMICS MARKET DYNAMICS
  • TABLE 7. GLOBAL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PROTEOMICS MARKET SIZE, BY AFFINITY CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PROTEOMICS MARKET SIZE, BY GAS CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PROTEOMICS MARKET SIZE, BY ION CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PROTEOMICS MARKET SIZE, BY LIQUID CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PROTEOMICS MARKET SIZE, BY SUPERFICIAL CHROMATOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PROTEOMICS MARKET SIZE, BY EDMAN SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PROTEOMICS MARKET SIZE, BY CAPILLARY ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PROTEOMICS MARKET SIZE, BY GEL ELECTROPHORESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PROTEOMICS MARKET SIZE, BY FOURIER TRANSFORM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PROTEOMICS MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN FRACTIONATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PROTEOMICS MARKET SIZE, BY BIOCHIP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PROTEOMICS MARKET SIZE, BY FUNCTIONAL PROTEIN MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PROTEOMICS MARKET SIZE, BY SURFACE PLASMON RESONANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PROTEOMICS MARKET SIZE, BY X RAY CRYSTALLOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PROTEOMICS MARKET SIZE, BY SPECTROMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PROTEOMICS MARKET SIZE, BY BUFFERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PROTEOMICS MARKET SIZE, BY STAINS & DYES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PROTEOMICS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS DATABASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS TOOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PROTEOMICS MARKET SIZE, BY DATA ACQUISITION SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PROTEOMICS MARKET SIZE, BY DATA ANALYSIS SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PROTEOMICS MARKET SIZE, BY BIOINFORMATICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PROTEOMICS MARKET SIZE, BY CORE PROTEOMICS SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PROTEOMICS MARKET SIZE, BY CANCER BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PROTEOMICS MARKET SIZE, BY CARDIOVASCULAR BIOMARKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL PROTEOMICS MARKET SIZE, BY DISEASE DIAGNOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL PROTEOMICS MARKET SIZE, BY THERAPEUTIC DRUG MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL PROTEOMICS MARKET SIZE, BY LEAD COMPOUND IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL PROTEOMICS MARKET SIZE, BY TARGET IDENTIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL PROTEOMICS MARKET SIZE, BY CORE RESEARCH FACILITIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL PROTEOMICS MARKET SIZE, BY UNIVERSITY LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL PROTEOMICS MARKET SIZE, BY CLINICAL TESTING DEPARTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL PROTEOMICS MARKET SIZE, BY PATHOLOGY LABS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL PROTEOMICS MARKET SIZE, BY DRUG MANUFACTURING UNIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL PROTEOMICS MARKET SIZE, BY R&D LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 75. AMERICAS PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. AMERICAS PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 77. AMERICAS PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 78. AMERICAS PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 79. AMERICAS PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 80. AMERICAS PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. AMERICAS PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 82. AMERICAS PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 83. AMERICAS PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 84. AMERICAS PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 85. AMERICAS PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. AMERICAS PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 87. AMERICAS PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 88. AMERICAS PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 89. AMERICAS PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. AMERICAS PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 91. AMERICAS PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 92. AMERICAS PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 93. AMERICAS PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 94. ARGENTINA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. ARGENTINA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 96. ARGENTINA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 97. ARGENTINA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 98. ARGENTINA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 99. ARGENTINA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. ARGENTINA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 101. ARGENTINA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. ARGENTINA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 103. ARGENTINA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 104. ARGENTINA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. ARGENTINA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 106. ARGENTINA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 107. ARGENTINA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 108. ARGENTINA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 109. ARGENTINA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 110. ARGENTINA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 111. ARGENTINA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 112. BRAZIL PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. BRAZIL PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 114. BRAZIL PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 115. BRAZIL PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 116. BRAZIL PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 117. BRAZIL PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. BRAZIL PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 119. BRAZIL PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 120. BRAZIL PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 121. BRAZIL PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 122. BRAZIL PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. BRAZIL PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 124. BRAZIL PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 125. BRAZIL PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 126. BRAZIL PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 127. BRAZIL PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 128. BRAZIL PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 129. BRAZIL PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 130. CANADA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. CANADA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 132. CANADA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 133. CANADA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 134. CANADA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 135. CANADA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. CANADA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 137. CANADA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. CANADA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 139. CANADA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 140. CANADA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 141. CANADA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 142. CANADA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 143. CANADA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 144. CANADA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. CANADA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 146. CANADA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 147. CANADA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 148. MEXICO PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. MEXICO PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 150. MEXICO PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 151. MEXICO PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 152. MEXICO PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 153. MEXICO PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. MEXICO PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 155. MEXICO PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 156. MEXICO PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 157. MEXICO PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 158. MEXICO PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. MEXICO PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 160. MEXICO PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 161. MEXICO PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 162. MEXICO PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 163. MEXICO PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 164. MEXICO PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 165. MEXICO PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 166. UNITED STATES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. UNITED STATES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 168. UNITED STATES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 169. UNITED STATES PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 170. UNITED STATES PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 171. UNITED STATES PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. UNITED STATES PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 173. UNITED STATES PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 174. UNITED STATES PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 175. UNITED STATES PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 176. UNITED STATES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. UNITED STATES PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED STATES PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED STATES PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED STATES PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED STATES PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED STATES PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED STATES PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED STATES PROTEOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 185. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 197. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 198. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 199. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC PROTEOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 204. AUSTRALIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. AUSTRALIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 206. AUSTRALIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 207. AUSTRALIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 208. AUSTRALIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 209. AUSTRALIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. AUSTRALIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 211. AUSTRALIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 212. AUSTRALIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 213. AUSTRALIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 214. AUSTRALIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. AUSTRALIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 216. AUSTRALIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 217. AUSTRALIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 218. AUSTRALIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 219. AUSTRALIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 220. AUSTRALIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 221. AUSTRALIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 222. CHINA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. CHINA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 224. CHINA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 225. CHINA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 226. CHINA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 227. CHINA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. CHINA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 229. CHINA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. CHINA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 231. CHINA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 232. CHINA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. CHINA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 234. CHINA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 235. CHINA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 236. CHINA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. CHINA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 238. CHINA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 239. CHINA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 240. INDIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 241. INDIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 242. INDIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 243. INDIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 244. INDIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 245. INDIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. INDIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 247. INDIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 248. INDIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 249. INDIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 250. INDIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 251. INDIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 252. INDIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 253. INDIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 254. INDIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 255. INDIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 256. INDIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 257. INDIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 258. INDONESIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 259. INDONESIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 260. INDONESIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 261. INDONESIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 262. INDONESIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 263. INDONESIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 264. INDONESIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 265. INDONESIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 266. INDONESIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 267. INDONESIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 268. INDONESIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 269. INDONESIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 270. INDONESIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 271. INDONESIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 272. INDONESIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 273. INDONESIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 274. INDONESIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 275. INDONESIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 276. JAPAN PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 277. JAPAN PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 278. JAPAN PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 279. JAPAN PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 280. JAPAN PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 281. JAPAN PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. JAPAN PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 283. JAPAN PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 284. JAPAN PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 285. JAPAN PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 286. JAPAN PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. JAPAN PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 288. JAPAN PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 289. JAPAN PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 290. JAPAN PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 291. JAPAN PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 292. JAPAN PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 293. JAPAN PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 294. MALAYSIA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 295. MALAYSIA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 296. MALAYSIA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 297. MALAYSIA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 298. MALAYSIA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 299. MALAYSIA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. MALAYSIA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 301. MALAYSIA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 302. MALAYSIA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 303. MALAYSIA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 304. MALAYSIA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. MALAYSIA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 306. MALAYSIA PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 307. MALAYSIA PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 308. MALAYSIA PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. MALAYSIA PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 310. MALAYSIA PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 311. MALAYSIA PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 312. PHILIPPINES PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 313. PHILIPPINES PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 314. PHILIPPINES PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 315. PHILIPPINES PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 316. PHILIPPINES PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 317. PHILIPPINES PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 318. PHILIPPINES PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 319. PHILIPPINES PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 320. PHILIPPINES PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 321. PHILIPPINES PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 322. PHILIPPINES PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 323. PHILIPPINES PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 324. PHILIPPINES PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 325. PHILIPPINES PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 326. PHILIPPINES PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 327. PHILIPPINES PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 328. PHILIPPINES PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 329. PHILIPPINES PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 330. SINGAPORE PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 331. SINGAPORE PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 332. SINGAPORE PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 333. SINGAPORE PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 334. SINGAPORE PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 335. SINGAPORE PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 336. SINGAPORE PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 337. SINGAPORE PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 338. SINGAPORE PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 339. SINGAPORE PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 340. SINGAPORE PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 341. SINGAPORE PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 342. SINGAPORE PROTEOMICS MARKET SIZE, BY CLINICAL DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 343. SINGAPORE PROTEOMICS MARKET SIZE, BY DRUG DISCOVERY, 2018-2030 (USD MILLION)
  • TABLE 344. SINGAPORE PROTEOMICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 345. SINGAPORE PROTEOMICS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 346. SINGAPORE PROTEOMICS MARKET SIZE, BY HOSPITAL & DIAGNOSTIC CENTERS, 2018-2030 (USD MILLION)
  • TABLE 347. SINGAPORE PROTEOMICS MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2030 (USD MILLION)
  • TABLE 348. SOUTH KOREA PROTEOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 349. SOUTH KOREA PROTEOMICS MARKET SIZE, BY CHROMATOGRAPHY, 2018-2030 (USD MILLION)
  • TABLE 350. SOUTH KOREA PROTEOMICS MARKET SIZE, BY ELECTROPHORESIS, 2018-2030 (USD MILLION)
  • TABLE 351. SOUTH KOREA PROTEOMICS MARKET SIZE, BY MASS SPECTROMETRY, 2018-2030 (USD MILLION)
  • TABLE 352. SOUTH KOREA PROTEOMICS MARKET SIZE, BY PROTEIN MICROARRAYS, 2018-2030 (USD MILLION)
  • TABLE 353. SOUTH KOREA PROTEOMICS MARKET SIZE, BY INSTRUMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 354. SOUTH KOREA PROTEOMICS MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
  • TABLE 355. SOUTH KOREA PROTEOMICS MARKET SIZE, BY REAGENTS & CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 356. SOUTH KOREA PROTEOMICS MARKET SIZE, BY SOFTWARE, 2018-2030 (USD MILLION)
  • TABLE 357. SOUTH KOREA PROTEOMICS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
  • TABLE 358. SOUTH KOREA PROTEOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 359. SOUTH KOREA PROTEOMICS MARKET SIZE, BY BIOMARKER IDENTIFICATION, 2018-2030 (USD MILLION)
  • TABLE 360. SOUTH KOREA PROTEOMICS MARKET SIZE, BY CLINIC